Cetera Trust Company N.A lowered its position in shares of Albemarle Co. (NYSE:ALB – Free Report) by 5.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,085 shares of the specialty chemicals company’s stock after selling 125 shares during the quarter. Cetera Trust Company N.A’s holdings in Albemarle were worth $179,000 as of its most recent SEC filing.
A number of other large investors have also made changes to their positions in ALB. American Century Companies Inc. raised its holdings in shares of Albemarle by 2.4% during the second quarter. American Century Companies Inc. now owns 27,241 shares of the specialty chemicals company’s stock valued at $2,602,000 after acquiring an additional 640 shares during the period. XTX Topco Ltd increased its stake in Albemarle by 24.2% in the 2nd quarter. XTX Topco Ltd now owns 3,035 shares of the specialty chemicals company’s stock valued at $290,000 after buying an additional 591 shares during the period. Ensign Peak Advisors Inc increased its stake in Albemarle by 6.2% in the 2nd quarter. Ensign Peak Advisors Inc now owns 146,459 shares of the specialty chemicals company’s stock valued at $13,990,000 after buying an additional 8,528 shares during the period. 1832 Asset Management L.P. increased its stake in Albemarle by 879,311.8% in the 2nd quarter. 1832 Asset Management L.P. now owns 149,500 shares of the specialty chemicals company’s stock valued at $14,280,000 after buying an additional 149,483 shares during the period. Finally, Public Sector Pension Investment Board increased its stake in Albemarle by 70.1% in the 2nd quarter. Public Sector Pension Investment Board now owns 4,499 shares of the specialty chemicals company’s stock valued at $430,000 after buying an additional 1,854 shares during the period. Institutional investors and hedge funds own 92.87% of the company’s stock.
Analyst Ratings Changes
Several research analysts have weighed in on ALB shares. Mizuho dropped their price objective on shares of Albemarle from $110.00 to $105.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 7th. Robert W. Baird upped their price objective on shares of Albemarle from $79.00 to $103.00 and gave the company a “neutral” rating in a research note on Wednesday, December 18th. KeyCorp dropped their price objective on shares of Albemarle from $132.00 to $127.00 and set an “overweight” rating on the stock in a research note on Tuesday, November 12th. Oppenheimer dropped their price target on shares of Albemarle from $171.00 to $170.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. Finally, Wells Fargo & Company increased their price target on shares of Albemarle from $100.00 to $110.00 and gave the stock an “equal weight” rating in a research note on Tuesday, October 8th. One investment analyst has rated the stock with a sell rating, fifteen have assigned a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $115.65.
Albemarle Price Performance
Shares of Albemarle stock opened at $92.67 on Wednesday. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.44 and a quick ratio of 1.58. Albemarle Co. has a fifty-two week low of $71.97 and a fifty-two week high of $143.19. The firm has a fifty day moving average price of $97.77 and a two-hundred day moving average price of $93.77. The company has a market cap of $10.89 billion, a PE ratio of -5.55, a price-to-earnings-growth ratio of 3.49 and a beta of 1.58.
Albemarle Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Thursday, January 2nd. Stockholders of record on Friday, December 13th were paid a $0.405 dividend. This represents a $1.62 dividend on an annualized basis and a dividend yield of 1.75%. The ex-dividend date of this dividend was Friday, December 13th. Albemarle’s dividend payout ratio is -9.67%.
Insider Activity
In related news, CEO J Kent Masters sold 2,525 shares of the stock in a transaction dated Thursday, December 5th. The shares were sold at an average price of $101.12, for a total transaction of $255,328.00. Following the completion of the sale, the chief executive officer now owns 73,747 shares in the company, valued at $7,457,296.64. This trade represents a 3.31 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 0.38% of the company’s stock.
Albemarle Profile
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.
Recommended Stories
- Five stocks we like better than Albemarle
- With Risk Tolerance, One Size Does Not Fit All
- Tempus AI: A Game-Changer in AI-Powered Healthcare
- Do ETFs Pay Dividends? What You Need to Know
- Pelosi Bets Big on AI: This Is What You Need to Know
- What Are Dividend Challengers?
- Mobileye’s High Short Interest Signals Squeeze Potential
Receive News & Ratings for Albemarle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Albemarle and related companies with MarketBeat.com's FREE daily email newsletter.